4.7 Article

Defibrinogen Therapy for Acute Ischemic Stroke: 1332 Consecutive Cases

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Endovascular vs medical management of acute ischemic stroke

Ching-Jen Chen et al.

NEUROLOGY (2015)

Article Cardiac & Cardiovascular Systems

Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke

Marta Swarowska et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)

Article Clinical Neurology

Impact of Stroke Care Unit on Patient Outcomes in a Community Hospital

Alexander Tamm et al.

STROKE (2014)

Review Medicine, General & Internal

Fibrinogen depleting agents for acute ischaemic stroke

Zilong Hao et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)

Article Neurosciences

Ancrod for Acute Ischemic Stroke: A New Dosing Regimen Derived from Analysis of Prior Ancrod Stroke Studies

David E. Levy et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2009)

Article Clinical Neurology

Hyperfibrinogenemia and Functional Outcome From Acute Ischemic Stroke

Gregory J. del Zoppo et al.

STROKE (2009)

Article Clinical Neurology

The impact of recanalization on ischemic stroke outcome - A meta-analysis

Joung-Ho Rha et al.

STROKE (2007)

Article Clinical Neurology

1,026 experimental treatments in acute stroke

VE O'Collins et al.

ANNALS OF NEUROLOGY (2006)

Article Clinical Neurology

Time is brain - Quantified

JL Saver

STROKE (2006)

Article Medicine, General & Internal

Intravenous ancrod for treatment of acute ischemic stroke - The STAT study: A randomized controlled trial

DG Sherman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)